Cardio-renal protective effect and safety of sodium-glucose cotransporter 2 inhibitors for chronic kidney disease patients with eGFR < 60 mL/min/1.73 m2: a systematic review and meta-analysis

Cardio-renal protective effect and safety of sodium-glucose cotransporter 2 inhibitors for chronic kidney disease patients with eGFR < 60 mL/min/1.73 m2: a systematic review and meta-analysis

Abstract Objective This meta-analysis was designed to investigate cardio-renal outcomes and safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) as a therapeutic option among chronic kidney disease(CKD) patients with GFR < 60 mL/min/1.73 m2, regardless of their diabetic status. Method We...

Full description

Saved in:
Bibliographic Details
Main Authors: Yaru Zhang, Junhui Luo, Bingxin Li, Junying Xu, Hong Yu, Nanlan Chen
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Nephrology
Subjects:
Cardiovascular outcomes
Renal outcomes
Safety
SGLT2i
Chronic kidney disease
Meta-analysis
Online Access:https://doi.org/10.1186/s12882-024-03833-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12882-024-03833-2

Similar Items